trimetazidine has been researched along with Renal Insufficiency in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors | Studies |
---|---|
Arora, D; Böhmert, S; de Voogd, H; Domahidy, M; Jain, S; Kaplan, S; Nenchev, N; Ramos, RS; Samad, A; Skopek, J | 1 |
Fu, H; Fu, N; Fu, X; Li, W; Liu, X; Yang, S; Zeng, Z; Zhang, H; Zhang, J; Zhang, P; Zhang, X | 1 |
Jangra, M; Khurana, A; Muddebihal, A; Singh, S | 1 |
Chen, F; Jin, Y; Liu, F; Lu, J; Xiao, B; Yang, X; Zhang, J | 1 |
Shehata, M | 1 |
Dai, W; Guo, W; Li, H; Li, L; Lu, H; Su, Q; Yang, H; Ye, Z | 1 |
Barré, J; Brakenhoff, JP; Ledudal, P; Oosterhuis, B; Sollie, FA; Tran, D; Wilkens, G | 1 |
Bouchier-Hayes, D; Creagh, T; Dolan, J; Lanigan, D; Tormey, W; Walshe, JJ | 1 |
1 review(s) available for trimetazidine and Renal Insufficiency
Article | Year |
---|---|
Clinical effect of trimetazidine on prevention of contrast-induced nephropathy in patients with renal insufficiency: An updated systematic review and meta-analysis.
Topics: Contrast Media; Creatinine; Humans; Incidence; Renal Insufficiency; Trimetazidine; Vasodilator Agents | 2017 |
4 trial(s) available for trimetazidine and Renal Insufficiency
Article | Year |
---|---|
Effect of age and renal impairment on the pharmacokinetics and safety of trimetazidine: An open-label multiple-dose study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Renal Insufficiency; Trimetazidine; Vasodilator Agents | 2020 |
Trimetazidine can prevent the occurrence of contrast-induced nephropathy after percutaneous coronary intervention in elderly patients with renal insufficiency.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Creatinine; Humans; Kidney Diseases; Percutaneous Coronary Intervention; Renal Insufficiency; Trimetazidine | 2021 |
Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study
Topics: Acute Kidney Injury; Aged; Animals; Antioxidants; Cardiac Catheterization; Contrast Media; Coronary Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Trimetazidine; Ubiquinone | 2018 |
Impact of trimetazidine on incidence of myocardial injury and contrast-induced nephropathy in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention.
Topics: Contrast Media; Coronary Angiography; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Elective Surgical Procedures; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Percutaneous Coronary Intervention; Prospective Studies; Renal Insufficiency; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2014 |
3 other study(ies) available for trimetazidine and Renal Insufficiency
Article | Year |
---|---|
Trimetazidine, a hitherto unreported cause of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome.
Topics: Cardiomyopathy, Dilated; Drug Hypersensitivity Syndrome; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Middle Aged; Prednisolone; Renal Dialysis; Renal Insufficiency; Trimetazidine; Vasodilator Agents | 2021 |
Pharmacokinetic profile of a modified release formulation of trimetazidine (TMZ MR 35 mg) in the elderly and patients with renal failure.
Topics: Adolescent; Adult; Age Factors; Aged; Aging; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Renal Insufficiency; Tablets; Trimetazidine | 2003 |
Pharmacological manipulation of acute cyclosporin ischemic renal injury with trimetazidine.
Topics: Animals; Cyclosporine; Dogs; Ischemia; Kidney; Renal Insufficiency; Trimetazidine | 1993 |